Karyopharm Therapeutics
KPTI
KPTI
90 hedge funds and large institutions have $298M invested in Karyopharm Therapeutics in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.32% more ownership
Funds ownership: 4.06% → 4.38% (+0.32%)
6% less capital invested
Capital invested by funds: $316M → $298M (-$17.9M)
Holders
90
Holding in Top 10
–
Calls
$1.19M
Puts
$242K
Top Buyers
| 1 | +$32.2M | |
| 2 | +$1.92M | |
| 3 | +$720K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$659K |
| 5 |
Millennium Management
New York
|
+$633K |
Top Sellers
| 1 | -$3.88M | |
| 2 | -$2.36M | |
| 3 | -$1.16M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.03M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
-$960K |